Clinical Trial News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2007
February 13, 2007
- Study Published in British Medical Journal The Lancet Shows Aromasin Improves Overall Survival in Breast Cancer Patients
- BioLineRx Successfully Completes Phase 1 Clinical Trials of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
- New Survey Reveals Nurses and Patients See Limitations of Commonly Used Method of Postoperative Pain Management
- Flu Shot Might Also Offer Some Protection Against H5N1
February 14, 2007
- Peregrine Pharmaceuticals Reports Positive Phase Ib Results for its Targeted Immunotherapy Bavituximab in Chronic Hepatitis C Infection
- Genta Cites Publication of Study Showing Improved Outcomes in CLL Patients Treated With Genasense Plus Chemotherapy
- Clinical Data Supporting Development of ChemGenex's Ceflatonin in Imatinib-Resistant CML Published in Cancer
- Morria Biopharmaceuticals Plc. Announces Publication of the Results of Its Human Pilot Study in Contact Dermatitis Patients of MRX1, a Novel First-in-Class MFAID
- Study Assesses New Communication Techniques Designed to Improve Dialogue About Migraine Between Healthcare Professionals and Patients
- New Instrument Developed to Measure Impact of Migraine on Patients' Lives When They Are Not Experiencing an Attack
- Protein Sensor for Fatty Acid Buildup in Mitochondria
- Genta Cites Publication of Study Showing Improved Outcomes in CLL Patients Treated with Genasense Plus Chemotherapy
- Hemispherx Avian Flu Prevention/Treatment Program Announces New Primate Results and Expands in both Europe and Southern Hemisphere
- Halozyme Therapeutics and Baxter Present Promising Results for the Use of Hylenex From the Infuse-Morphine Study
February 15, 2007
- The Immune Response Corporation's Interim Phase II Data Suggest Both REMUNE and IR103 Stabilize CD4+ Cell Counts in Drug-Naive HIV Patients
- Unique Structure of Geron's Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic Activity in Lung Cancer Cells
- Alagebrium Demonstrates Cardiovascular Activity in Recently Published Report Indicating Potential Wide-Ranging Benefits in Cardiovascular Diseases
- Positive Results with Lacosamide in Diabetic Neuropathic Pain in Phase III Trial
- Survey Finds Perceived Risk of Recurrence is Low in African American Breast Cancer Survivors
- Gene Network Sciences and UCSD Researchers Discover Connection Between Metabolic Pathways and Cancer
- Nasal Flu Vaccines Provide 'Double' Immunity, Carrington Labs Says
- CDC Report Provides First State-Specific Data on Persons Living With Heart Disease
- Researchers Discover New Details About HIV-1 Entry and Infection
- OXiGENE Announces Positive Results from its Phase II CA4P Clinical Trial in Myopic Macular Degeneration (MMD-213)
February 16, 2007
- Inovio Biomedical DNA Delivery Technology Presented by Wyeth Researcher at Vaccine Conference
- Preclinical Efficacy Data on Medivation's MDV3100 to Be Presented at ASCO-sponsored Prostate Cancer Symposium
- New Study Shows Cough Medicine Effective Against Prostate Cancer
- GPC Biotech Schedules Conference Call to Discuss Results from the Satraplatin Phase 3 Trial Being Presented at the ASCO Prostate Cancer Symposium in Orlando, Florida
- Researchers Discover "Sticky" Proteins Fuse Adult Stem Cells to Cardiac Muscle, Repairing Hearts
- Mayo Clinic Investigators Demonstrate Degradation of Key Abnormal Alzheimer's Disease Protein
- Amgen to Hold Analyst Call to Discuss Danish Head and Neck Cancer (DAHANCA) 10 Study
February 20, 2007
- Auxilium Announces Results from Phase III Trial that Show AA4500 Successful in Treating Dupuytren's Contracture
- Vyteris Releases Study Estimating the Market for Lidosite Between $200M - $500M for Use Prior to Blood Draws
- Alteon's Investigational Drug Alagebrium Demonstrates Ability to Improve Functional Membrane Transport in a Rat Model of Chronic Peritoneal Dialysis, Indicating a Potential Role in Kidney Disease
- Basilea Reports Positive Phase III Results for Alitretinoin
- BioMarin Announces Results From Phase 2 Clinical Study of 6R-BH4 in Poorly Controlled Hypertension
- CeNeS Pharmaceuticals plc Announces Successful Phase III Results on Lead Product M6G
- Psoriasis Foundation Consensus Statement Examines Psoriasis Severity in a New Light
- H. Lee Moffitt Researchers Discover Potential Targets to Reduce Risk of Stem Cell Transplants
- New Data Support AlphaVax's Vaccine for CMV
- The Medicines Company Supports Landmark Patient Observational Study and Clinical Survey on Acute Severe Hypertension
- Researchers Funded by The Leukemia & Lymphoma Society Studying Agent to Target Gene Linked to Many Forms of Lymphoma
- RNAi Shows Promise in Gene Therapy, Stanford Researcher Says
- Stanford Q&A: Largest-Ever Study Shows Possible Genetic Links for Autism
- Successful Phase III results announced on Lead Product M6G
- FDA Warns About Erythropoiesis Stimulating Agents (ESAs) - Results of Aranesp Study May Apply to Other ESAs
- Largest-Ever Search for Autism Genes Reveals New Clues
February 21, 2007
- GTx Announces Presentation of Acapodene Data At ASCO Prostate Cancer Symposium
- BioSante Pharmaceuticals to Present LibiGel at International Society for the Study of Women's Sexual Health (ISSWSH) Annual Meeting
- Sepracor Announces Publication of Additional Data from Lunesta Insomnia-Depression Study in the Journal of Clinical Sleep Medicine
- Pre-Clinical Study of Novavax's Seasonal Influenza Vaccine Published in Journal 'Vaccine'
- New Long-term Data Published in Journal of Clinical Oncology Support That Femara Is More Effective Than Tamoxifen
- Experimental Vaccine Given During Pregnancy Reduces Stillbirths from Common Virus
February 22, 2007
- Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
- Hollis-Eden Pharmaceuticals Presents Additional Positive Data with Novel Steroid Hormone in Models of Prostate and Breast Cancer
- Poniard Pharmaceuticals Announces Picoplatin Abstract Accepted for Publication by ASCO's 2007 Prostate Cancer Symposium
- Cell Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase 1 Combination Therapy Trial With GVAX(TM) Immunotherapy for Prostate Cancer and Ipilimumab (MDX-010) Antibody
- Analysis of International Phase III Study of Avastin Plus Chemotherapy Shows Improved Progression-Free Survival in Patients With Advanced Lung Cancer
- Allegiance Equity Corporation Announces Positive Results of In Vitro Studies and an Open Label Trial for Relieva in Treating Atopic Dermatitis
- MediciNova to Present Phase II Clinical Trial Results for MN-001, a Novel Oral Treatment for Bronchial Asthma, at the 2007 AAAAI Annual Meeting
- CureDM, Inc. Achieves Two Drug Discovery Milestones
February 23, 2007
- GTx's ACAPODENE Interim Bone Mineral Density and Lipid Data Highlighted at Press Briefing at Prostate Cancer Symposium of the American Society of Clinical Oncology
- Spectrum Pharmaceuticals Announces Satraplatin Data Presentation at the American Society of Clinical Oncology Prostate Cancer Symposium
- Satraplatin Shown to Significantly Reduce Risk of Disease Progression in Advanced Hormone-Refractory Prostate Cancer Patients
- Significant Phase III Results With Cimzia in Rheumatoid Arthritis
- Defibrotide Highlighted in Presentation at the 51st Meeting of the German Society for Thrombosis and Hemostasis
- Update on Cortex's CEO Presentation at the Roth Capital Partners 19th Annual Conference
- Crutchfield Dermatology Reports a New Wrinkle in the Quest for Smooth and Youthful Skin
- Dynavax Reports Interim, One-Year Data From Ragweed Allergy Trial at AAAAI
- Dynavax Announces Webcast on AAAAI Data and 2007 Financial Outlook
- Treatment Extends Survival in Mouse Model of Spinal Muscular Atrophy
- Gamunex Is the Preferred Liquid IGIV Therapy Among Allergists and Immunologists Surveyed
- Protox Announces PRX302 Data to Be Presented at ASCO Sponsored Prostate Cancer Symposium
- Positive AS1404 Trial Data Presented at ASCO Prostate Cancer Symposium
- Cougar Biotechnology Announces Presentation of Positive Phase I and Phase II Data at ASCO Prostate Cancer Symposium
February 26, 2007
- 'Encouraging' Major Responses Seen With Xyotax in Patients With Taxane-Resistant Androgen Independent Prostate Cancer
- Palatin Technologies and King Pharmaceuticals Announce Presentation Regarding Clinical Study Evaluating Bremelanotide in Post-Menopausal Female Sexual Dysfunction Patients
- Physicians Still Treating Acute Otitis Media (AOM) as They Did Prior to PCV-7
- LifeCycle Pharma Announces Positive Data From LCP-AtorFen Phase I Clinical Program
- Steroid-Free Astelin Nasal Spray Demonstrated Seasonal Allergy Symptom Improvement Within 15 Minutes in Clinical Study
- Drug Treatment Improves Learning in Mice With Down Syndrome Symptoms, Stanford/Packard Study Shows
- Hollis-Eden Pharmaceuticals Reports Publication of Results Demonstrating the Ability of Neumune to Increase Survival in a Primate Model of Lethal Radiation Injury
- Othera Pharmaceuticals Presents New AMD Data at Angiogenesis 2007 Symposium
- Phase 3 Stroke Trial Shows That Novoseven Reduces Bleeding in the Brain, but Does Not Improve Long-term Clinical Outcomes
- Survey Shows Discomfort With Existing Nasal Sprays Causes Allergic Rhinitis Patients to Discontinue Treatment
- Medivation's MDV3100 Shown to Be Effective in a Preclinical Model of Hormone-Refractory Prostate Cancer
- Gilead Announces Completion of Phase II Clinical Trial of Novel Investigational HIV Integrase Inhibitor GS 9137
- Algeta's Alpharadin significantly improves patient survival in a clinical trial in prostate cancer
- Avigen's AV411 Highlighted in Special Issue of Neuron Glia Biology
- New Clinical Data for Prostascint and Quadramet in Prostate Cancer Presented at the 2007 Prostate Cancer Symposium
- Phase 2 Results of Genasense Plus Chemotherapy in Advanced Prostate Cancer Reported at Cancer Conference
- LifeCycle Pharma announces positive data from LCP-AtorFen Phase I clinical program
February 27, 2007
- MAP Pharmaceuticals Reports Positive Phase 2 Results for its Pediatric Asthma Drug Candidate
- Post-Hoc Data Analyses Published in Annals of Neurology Found Copaxone Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
- Increased Prescription Drug Co-pays Linked to Lower Medication Usage and Higher Hospitalization Rates, Thomson Medstat Study Finds
- Reported to the American Academy of Allergy, Asthma and Immunology: Pittsburgh Study Suggests Asthma Medication May Provide Relief for the Common Cold
- MatTek's EpiVaginal Excels in Microbicide/HIV Research Study
- Podcast Alert: Dr. Eli Meltzer Discusses New Data on Fluticasone Furoate Nasal Spray
- Studies Showed Fluticasone Furoate Nasal Spray Was Well-Tolerated and Effective in Treating Allergic Rhinitis in Pediatric Patients
- New Data Showed Fluticasone Furoate Nasal Spray Effectively Treated Nasal Symptoms of Allergic Rhinitis
- Study Finds C1-Inhibitor Concentrate Is Safe and Effective in Treating Skin Swelling in Patients With Hereditary Angioedema
- Genitope Corporation to Host Conference Call to Discuss Updated Blinded Data from Its Phase 3 Clinical Trial
February 28, 2007
- TargeGen Announces Successful Completion of Phase I Clinical Trial of Topical AMD Drug TG100801
- Beech Tree Labs' ML-05 Addresses External and Internal Scars
- Nymox Reports Completion of New Long-term Study of NX-1207 for BPH
- Mayo Clinic Researchers Safely Regenerate Failing Mouse Hearts With Programmed Embryonic Stem Cells
- IL-1 Trap Phase 3 Trial Data Presented at Annual Meeting of American Academy of Allergy, Asthma and Immunology (AAAAI)
- Human Genome Sciences Announces Positive Interim Results of Phase 2b Trial of Albuferon With Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C
- Review of 1918 Pandemic Flu Studies Offers More Questions than Answers
